HK Stock Market Move | CHINA RISUN GP (01907) rises more than 5% with the imminent start of the ethylenediamine plant. Institutions are optimistic about its chemical sector contributing to earnings elasticity.

China Risun GP (01907) rose more than 5% in the afternoon, with an increase of 5.52% as of press time, closing at HK$3.25, with a turnover of HK$1.13 billion. On the news front, Xuyang Group announced at the beginning of the month that its independently developed caprolactam to hexamethylene diamine unit completed catalyst filling on March 30, 2026, laying the foundation for production in April, with an expected annual output of about 30,000 tons in 2026. Debon Securities pointed out that looking ahead to 2026, with the ongoing Middle East geopolitical crisis driving a significant increase in international oil prices, the company's chemical business is also expected to see a simultaneous sharp rise in prices (such as methanol and caprolactam market prices rising by over 60% and 30% respectively at the end of March compared to the beginning of the year). The company's many years of planning may lead to a significant period of harvest.